GlassScriptPhysician profile
Thao Giang
NPI 1508516279
$1,097.36
in general payments reported to CMS, 2019-2025
11 companies · $406 in 2025
The $406 reported for 2025 was more than what 75% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $277 · 2024: $414 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $953 · Education: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $953.44 |
| Education | $143.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $290.39 | 2025 | Ultreon, Ensite |
| Medtronic, INC. | $173.90 | 2024 | Symplicity G3 |
| Novo Nordisk INC | $124.26 | 2024 | Wegovy |
| Novartis Pharmaceuticals Corporation | $115.79 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $113.37 | 2023-2025 | Lokelma, Farxiga |
| Gilead Sciences, INC. | $101.32 | 2023 | Epclusa |
| Alnylam Pharmaceuticals INC. | $81.86 | 2023 | Amvuttra |
| Abiomed | $48.22 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.84 | 2025 | Jardiance |
| Teleflex LLC | $14.67 | 2025 | Trapliner |
| Bayer Healthcare Pharmaceuticals INC. | $13.74 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thao Giang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.